Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
QuintilesIMS
Deloitte
Argus Health
Johnson and Johnson
Express Scripts
Mallinckrodt
Cerilliant
US Army
UBS

Generated: December 12, 2017

DrugPatentWatch Database Preview

Barr Company Profile

« Back to Dashboard

What is the competitive landscape for BARR, and what generic and branded alternatives to BARR drugs are available?

BARR has one hundred and eighty-two approved drugs.

There are seven tentative approvals on BARR drugs.

Summary for Barr

US Patents:0
Tradenames:128
Ingredients:102
NDAs:182
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
BarrLEFLUNOMIDEleflunomideTABLET;ORAL077083-002Sep 13, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrCEPHALEXINcephalexinFOR SUSPENSION;ORAL062777-001Aug 6, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrDEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEamphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfateTABLET;ORAL040422-007Mar 19, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrBUPRENORPHINE HYDROCHLORIDEbuprenorphine hydrochlorideTABLET;SUBLINGUAL090360-001May 7, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrTRI-LEGEST 21ethinyl estradiol; norethindrone acetateTABLET;ORAL-21076405-001Oct 26, 2007RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrMEPERIDINE HYDROCHLORIDEmeperidine hydrochlorideTABLET;ORAL088639-001Jul 2, 1984AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Barr Labs IncCHLORTHALIDONEchlorthalidoneTABLET;ORAL088903-001Sep 19, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrISONIAZIDisoniazidTABLET;ORAL080937-002Approved Prior to Jan 1, 1982AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrASPIRIN AND DIPYRIDAMOLEaspirin; dipyridamoleCAPSULE, EXTENDED RELEASE;ORAL078804-001Aug 14, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrERYTHROMYCIN ETHYLSUCCINATEerythromycin ethylsuccinateTABLET;ORAL062256-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Novartis
QuintilesIMS
Baxter
Dow
Boehringer Ingelheim
Johnson and Johnson
Citi
Julphar
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot